Sanofi and Teva Pharmaceuticals, a U.S. subsidiary of Teva Pharmaceutical Industries Ltd. announce a collaboration to co-develop and co-commercialize asset TEV ‘574, currently in...
The U.S. Food and Drug Administration approved Tyruko, the first biosimilar to Tysabri (natalizumab) injection for the treatment of adults with relapsing forms of...
Merck, known as MSD outside the United States and Canada, and Prometheus Biosciences, Inc. announced that the companies have entered into a definitive agreement...
